|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Physical characterization and dissolution properties of Ibuprofen:Eudragit coprecipitates显示文摘 | Kislalioglu MS Khan MA Blount C | 1991 | J Pharm Sci1991，80，8： | 1 |
| 2 | Molecular prop- erties of mammalian proteins that interact with cGMP: protein ki- nases, cation channels, phosphodiesterases, and multi-drug anion transporters显示文摘 | Francis SH Blount MA Zoraghi R Corbin JD | 2005 | Front Biosci2005，10，： | 1 |
| 3 | High lung PDE5: a strong basis for treating pulmonary hypertension with PDE5 inhibitors 显示文摘 | Corbin JD Beasley A Blount MA | 2005 | Biochem Biophys Res Commun2005，334，3： | 1 |
| 4 | Vardenafil:structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5)显示文摘 | Corbin JD Beasley A Blount MA | 2004 | Neurochem Int2004，45，6： | 1 |
| 5 | High lung PDE5: A strong basis for treating pulmonary hypertension with PDE5 inhibitors 显示文摘 | CORBIN JD BEASLEY A BLOUNT MA | 2005 | Biochem Biophys Res Commun2005，334，3： | 1 |
| 6 | Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions显示文摘 | Francis SH Blount MA Corbin JD | 2011 | Physiol Rev2011，91，2： | 1 |
| 7 | Analysing a familycentred preoperative intervention programme:a dismantling approach显示文摘 | Fortier MA Blount RL Wang SM | 2011 | Br J Anaesth2011，106，5： | 1 |
| 8 | High lung PDE-5:a strong basis for treating pulmonary hypertension with PDE-5 inhibitors显示文摘 | Corbin JD Beasley A Blount MA F | 2005 | Biochem Biophys Res Commun2005，334，： | 1 |
| 9 | Binding of tritiated sildenafil,tadalafil,or vardenafil to the phosphodiesterase-5 catalyt ic site displays potency,specificity,heterogeneity,and cGMP stimulation显示文摘 | Blount MA Beasley A Zoraghi R | 2004 | Mol Pharmacol2004，66，1： | 1 |
| 10 | Vardenafil:structural basis for higher potency over sildenafil in inhibiting cGMP-specific phoshodiesterase-5 (PDE-5)显示文摘 | Corbin JD Beasley A Blount MA | 2004 | Neurochem Int2004，45，： | 1 |
| 11 | Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5(PDE5) 显示文摘 | Corbin JD Beasley A Blount MA | 2004 | Neurochem Int2004，45，6： | 1 |
| 12 | Physical characterization and dissolution properties of Ibuprofen:Eudragit coprecipitates显示文摘 | Kislalioglu MS Khan MA Blount C | 1991 | J Pharm Sci1991，80，8： | 1 |
| 13 | Vardenafil: structural basis for higher potency over sildenafil in inhibiting eGMP-specific phosphodiesterase-5 ( PDE5 ) 显示文摘 | Corhin JD Beasley A Blount MA | 2004 | Neuroehem Int2004，45，6： | 1 |
| 14 | Physical charaterization and dissolution properties of lbuprofen:Eudragit coprecipitates显示文摘 | Khan MA Blount C | 1991 | J Pharm Sci1991，80，8： | 1 |
| 15 | Molecular mechanisms of ureatransport in health and disease 显示文摘 | Klein JD Blount MA Sands JM | 2012 | Pflugers Arch2012，464，6： | 1 |
| 16 | Physical charaterization and dissolution properties of Ibuprofen:Eudragit coprecipitates显示文摘 | Kislalioglu MS Khan MA Blount C | 1991 | JPharm Sci1991，80，8： | 1 |
| 17 | Metformin, an AMPK activator,stimulates the phosphorylation of Aquaporin 2 and Urea TransporterAl in Inner Medullary Collecting Ducts 显示文摘 | Klein JD Wang Y Blount MA | 2016 | Am J Physiol - RenalPhysiol2016，310，10： | 1 |
| 18 | Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions显示文摘 | Francis SH Blount MA Corbin JD | 2011 | Physiol Rev2011，91，2： | 1 |
| 19 | Mammal/an cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological func- tions显示文摘 | Francis SH Blount MA Corbin JD | 2011 | Physiol Rev2011，91，2： | 1 |
| 20 | Metformin, an AMPK activator, stimulatesthe phosphorylation of Aquaporin 2 and Urea Transporter A1 in Inner MedullaryCollecting Ducts显示文摘 | Klein JD Wang Y Blount MA | 2016 | Am J Physiol Renal Physiol2016，0，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员